1. Home
  2. TYRA vs SCHL Comparison

TYRA vs SCHL Comparison

Compare TYRA & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • SCHL
  • Stock Information
  • Founded
  • TYRA 2018
  • SCHL 1920
  • Country
  • TYRA United States
  • SCHL United States
  • Employees
  • TYRA N/A
  • SCHL N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • TYRA Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • TYRA Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • TYRA 576.6M
  • SCHL 478.8M
  • IPO Year
  • TYRA 2021
  • SCHL 1987
  • Fundamental
  • Price
  • TYRA $9.52
  • SCHL $16.82
  • Analyst Decision
  • TYRA Strong Buy
  • SCHL
  • Analyst Count
  • TYRA 7
  • SCHL 0
  • Target Price
  • TYRA $30.86
  • SCHL N/A
  • AVG Volume (30 Days)
  • TYRA 298.0K
  • SCHL 246.5K
  • Earning Date
  • TYRA 05-08-2025
  • SCHL 07-17-2025
  • Dividend Yield
  • TYRA N/A
  • SCHL 4.63%
  • EPS Growth
  • TYRA N/A
  • SCHL N/A
  • EPS
  • TYRA N/A
  • SCHL 0.65
  • Revenue
  • TYRA N/A
  • SCHL $1,592,100,000.00
  • Revenue This Year
  • TYRA N/A
  • SCHL $3.42
  • Revenue Next Year
  • TYRA N/A
  • SCHL $5.47
  • P/E Ratio
  • TYRA N/A
  • SCHL $26.49
  • Revenue Growth
  • TYRA N/A
  • SCHL N/A
  • 52 Week Low
  • TYRA $6.42
  • SCHL $15.77
  • 52 Week High
  • TYRA $29.60
  • SCHL $38.77
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 45.60
  • SCHL 40.57
  • Support Level
  • TYRA $8.88
  • SCHL $16.81
  • Resistance Level
  • TYRA $9.68
  • SCHL $17.85
  • Average True Range (ATR)
  • TYRA 0.64
  • SCHL 0.66
  • MACD
  • TYRA -0.08
  • SCHL -0.11
  • Stochastic Oscillator
  • TYRA 26.98
  • SCHL 5.04

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: